Melan-A, a new melanocytic differentiation marker

Advances in Anatomic Pathology

Volumn 6, Issue 1, 1999, Pages 12-18

  Busam, K J ^a   Jungbluth, A A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiomyolipoma; Immunohistochemistry; MART 1; Melan A; Melanoma; Perivascular epithelioid cell tumor; Steroid cell tumor

Indexed keywords

DIFFERENTIATION ANTIGEN; MART1 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR PROTEIN;

ADRENAL CORTEX TUMOR; ANGIOMYOLIPOMA; BIOSYNTHESIS; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE METASTASIS; LYMPHANGIOLEIOMYOMATOSIS; MALE; MELANOCYTE; MELANOMA; METABOLISM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; REVIEW; SKIN TUMOR; TESTIS TUMOR;

ADRENAL CORTEX NEOPLASMS; ANGIOMYOLIPOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOLEIOMYOMATOSIS; LYMPHATIC METASTASIS; MALE; MELANOCYTES; MELANOMA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; SKIN NEOPLASMS; TESTICULAR NEOPLASMS;

EID: 0032602027     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-199901000-00002     Document Type: Article

References (27)

1. Van den Eynde B, Brichard VG. New tumor antigens recognized by T cells. Curr Opin Immunol 1995;7:674-81.
2. Jaeger E, Bernhard H, Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated petides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996;66:162-7.
3. Zhai Y, Yang J, Kawakami Y, et al. Antigen-specific tumor vaccines. J Immunol 1996; 156:700-10.
4. Coulie PG, Brichard V, van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42. (Pubitemid 24181053)
5. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9. (Pubitemid 24139460)
6. Butterfield LH, Stoll TC, Lau R, Economou JS. Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions. Gene 1997;191:129-34. (Pubitemid 27250091)
7. Chen YT, Stocken E, Jungbluth A, et al. Serologic analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl. Acad Sci 1996;93:5915-9. (Pubitemid 26191318)
8. Kawakami Y, Battles JK, Kabayashi T, et al. Production of recombinant MART-1 proteins and specific anti MART-1 polyclonal and monoclonbal antibodies: use in the characterization of the human melanoma antigen MART-1. J Immunol Meth 1997;202:13-25. (Pubitemid 27104263)
9. Jungbluth AA, Busam KJ, Gerald WL, et al. A103, an anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998;22:595-602. (Pubitemid 28213747)
10. Jungbluth AA, Iversen K, Coplan, K, et al. Expression of the melanocytic differentiation marker Melan-A/MART-1 in angiomyolipoma. An immunohistochemal and RT-PCR based analysis. Virchow Arch Pathol Anat (in press).
11. Fetsch PA, Cormier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin embedded malignant melanomas. J. Immunotherap 1996;20:60-4. (Pubitemid 28011524)
12. Marincola FM, Hijazi YM, Fetsch P, et al. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions. J Immunotherap 1996;19:192-205. (Pubitemid 26234613)
13. Beaty M, Fetsch P, Wilder A, Marincola F, Abati A. Effusion cytology of malignant melanoma: a morphologic and immunohistochemical analysis including application of the MART-1 antibody. Cancer 1997;81:57-63. (Pubitemid 28275329)
14. Busam KJ, Chen Y-T, Old LJ, et al. Expression of Melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998;22:976-82. (Pubitemid 28364497)
15. Busam KJ, Iversen K, Coplan KA, et al. Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998;22:57-63. (Pubitemid 28016752)
16. Krishnamurthy S, Jungbluth AA, Busam KJ, Rosai J. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consisten with true sex-cord differentiation. Am J Surg Pathol 1998;22:1078-82. (Pubitemid 28411065)
17. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. In: Atlas of Tumor Pathology, 3rd series, Fascicle 11. Washington, D.C. Armed Forces Institute of Pathology, 1994:161-74.
18. Colby TV, Koss MN, Travis WD. Tumors of the lower respiratory tract. In: Atlas of Tumor Pathology, 3rd series, Fascicle 13. Washington, D.C. Armed Forces Institute of Pathology, 1995:356-60.
19. Colby TV, Koss MN, Travis WD. Tumors of the lower respiratory tract. In: Atlas of Tumor Pathology, 3rd series, Fascicle 13. Washington, D.C. Armed Forces Institute of Pathology, 1995:471-4.
20. Pea M, Bonetti F, Zamboni G. et al. Melanocyte-marker HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991;23:185-8.
21. Sturtz C, Dabbs D. Angiomyolipomas: the nature and expression of the HMB-45 antigen. Mod Pathol 1994;7:842-5.
22. Chan, J. Tsang W, Pau M, et al. Lymphangioleiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993;22:445-55.
23. Pea M, Bonetti F. Zamboni G, Martignoni G, Fiore-Donati L. Clear cell tumor and angiomyolipoma. Am J Surg Pathol 1991;15:199-202.
24. Bonetti F, Pea M, Martignoni G, et al. Clear cell (sugar) tumor of the lung is a lesion strictly related to angiomyolipoma: the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994;26:230-6.
25. Bonetti F, Pea M, Martignoni G. et al. The perivascular epithelioid cell and related lesions. Adv Anat Pathol 1997;4:343-58.
26. Hoon V. Thung S, Kaneko M, Unger P. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 1994;118:732-4. (Pubitemid 24217606)
27. Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A. Comparison of melanoma antigen recognized by T-cells (MART-1) to HMB-45. Additional evidence to support a common lineage for angiomyolipoma. lymphangiomyomatosis, and clear cell sugar tumor. Mod Pathol 1998;11:699-703. (Pubitemid 28381601)